Net sales during the second quarter totaled
Before the second quarter, we saw indications of significantly increased demand during the second half-year and we expected a good full year. Instead, we received indications that involve delays in orders. Against this backdrop, in July, we announced a cost reduction program to adapt our organization and costs to the lower levels of flow plate production that we now expect. Based on the continued progress in the development of the industry combined with our customers' leading market positions we consider the current situation to be a temporary adjustment in production levels.
There is great interest in
Sales target 2025:
Sales target 2028: >
Profitability targets: EBITDA >15% in medium term
The EBITDA break-even is still expected to be reached in 2025 driven by greatly improved productivity through
Financial Summary
- Net sales totaled
SEK 17.2 million (20.4). -
Operating profit (EBIT) was
SEK -27.1 million (-21.8). -
The Group's result after financial items was
SEK -28.5 million (-22.2). -
Earnings per share attributable to the Parent Company's shareholders before and after dilution totaled
SEK -0.38 (-0.29). - Debt/equity ratio was 76 percent (87) on the balance sheet date.
-
Cash flows from operating activities amounted to
SEK -24.2 million (-40.0). -
On the balance sheet date, the Group's cash and cash equivalents totaled
SEK 79.5 million (219.7).
This information is inside information that
IR Contact
Pär Teike
CEO,
+46 73-024 06 84 or paer.teike@cellimpact.com
For more information, please contact:
Stefan Axellie
CFO,
+46 70-343 46 55 eller stefan.axellie@cellimpact.com
About
The
https://news.cision.com/cell-impact/r/cell-impact-q2-2023-temporary-lower-level-of-activity-and-cost-reduction-program,c3822668
https://mb.cision.com/Main/18253/3822668/2247340.pdf
https://mb.cision.com/Public/18253/3822668/96c9fb3f2975add5.pdf
(c) 2023 Cision. All rights reserved., source